Controlled-Release Transit is a gastrointestinal transit model that distinguishes itself by simulating the delayed and site-specific release of substances in the digestive tract through engineered mechanisms, enabling precise temporal and spatial delivery of therapeutic agents.
6
Publications
326
Citations
27
Authors
9
Institutions
Publications per year
2017–2026
0
Parents
Publications
6
1–5 of 6
Authors
27
- SD
3
h-index
- LC
2
h-index
- NW
2
h-index
- SM
2
h-index
- CW
2
h-index
1–5 of 27
Institutions
9
University of Nottingham
Nottingham, United Kingdom
4 h-index
14 publications
505 citations
Napp Pharmaceuticals (United Kingdom)
Cambridge, United Kingdom
2 h-index
5 publications
77 citations
Lund University
Lund, Sweden
1 h-index
2 publications
218 citations
AstraZeneca (Singapore)
Singapore, Singapore
1 h-index
1 publications
109 citations
AstraZeneca (Sweden)
Södertälje, Sweden
1 h-index
4 publications
436 citations
Queen's Medical Centre
Nottingham, United Kingdom
1 h-index
1 publications
30 citations
AstraZeneca (Germany)
Wedel, Germany
1 h-index
1 publications
109 citations
University of Utah
Salt Lake City, United States
1 h-index
5 publications
400 citations
1–8 of 9
Venues
- International Journal of Pharmaceutics
4 publications · 137 citations
4
h-index
- Journal of Controlled Release
1 publications · 80 citations
1
h-index
- Alimentary Pharmacology & Therapeutics
1 publications · 109 citations
1
h-index
1–3